LRIG1 acts as a critical regulator of melanoma cell invasion, migration, and vasculogenic mimicry upon hypoxia by regulating EGFR/ERK-triggered epithelial–mesenchymal transition
出版年份 2018 全文链接
标题
LRIG1 acts as a critical regulator of melanoma cell invasion, migration, and vasculogenic mimicry upon hypoxia by regulating EGFR/ERK-triggered epithelial–mesenchymal transition
作者
关键词
-
出版物
BIOSCIENCE REPORTS
Volume 39, Issue 1, Pages BSR20181165
出版商
Portland Press Ltd.
发表日期
2018-11-29
DOI
10.1042/bsr20181165
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Parthenolide suppresses hypoxia-inducible factor-1α signaling and hypoxia induced epithelial-mesenchymal transition in colorectal cancer
- (2017) Se Lim Kim et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Long noncoding RNA NORAD, a novel competing endogenous RNA, enhances the hypoxia-induced epithelial-mesenchymal transition to promote metastasis in pancreatic cancer
- (2017) Hongzhe Li et al. Molecular Cancer
- Upholding a role for EMT in breast cancer metastasis
- (2017) Xin Ye et al. NATURE
- Expression of LRIG proteins as possible prognostic factors in primary vaginal carcinoma
- (2017) Cecilia Ranhem et al. PLoS One
- Systemic Therapy for Metastatic Melanoma in 2012: Dawn of a New Era
- (2017) Shailender Bhatia et al. Journal of the National Comprehensive Cancer Network
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Effects of DDIT4 in Methamphetamine-Induced Autophagy and Apoptosis in Dopaminergic Neurons
- (2016) Bing Li et al. MOLECULAR NEUROBIOLOGY
- Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer
- (2016) Caroline Wigerup et al. PHARMACOLOGY & THERAPEUTICS
- LRIG1 inhibits hypoxia-induced vasculogenic mimicry formation via suppression of the EGFR/PI3K/AKT pathway and epithelial-to-mesenchymal transition in human glioma SHG-44 cells
- (2015) Xi Zhang et al. CELL STRESS & CHAPERONES
- Expression of LRIG1 is Associated With Good Prognosis for Human Non-small Cell Lung Cancer
- (2015) Yuzhi An et al. MEDICINE
- LRIG1 opposes epithelial-to-mesenchymal transition and inhibits invasion of basal-like breast cancer cells
- (2015) N Yokdang et al. ONCOGENE
- Hypoxia as a Cause of Treatment Failure in Non–Small Cell Carcinoma of the Lung
- (2015) Odd Terje Brustugun SEMINARS IN RADIATION ONCOLOGY
- Loss of LRIG1 Locus Increases Risk of Early and Late Relapse of Stage I/II Breast Cancer
- (2014) P. A. Thompson et al. CANCER RESEARCH
- Hypoxia promotes vasculogenic mimicry formation by inducing epithelial–mesenchymal transition in ovarian carcinoma
- (2014) Jing Du et al. GYNECOLOGIC ONCOLOGY
- Targeting tumour hypoxia to prevent cancer metastasis. From biology, biosensing and technology to drug development: the METOXIA consortium
- (2014) Erik O. Pettersen et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- ME-12 * THE TUMOR SUPPRESSOR LRIG1 IS DOWNREGULATED BY HYPOXIA AND REGULATES GLIOBLASTOMA CELL INVASION
- (2014) F. Mao et al. NEURO-ONCOLOGY
- Hypoxia Promotes Uveal Melanoma Invasion through Enhanced Notch and MAPK Activation
- (2014) Laura Asnaghi et al. PLoS One
- Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER
- (2014) Twan van den Beucken et al. Nature Communications
- Restoration of LRIG1 suppresses bladder cancer cell growth by directly targeting EGFR activity
- (2013) Lei Chang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Downregulation of LRIG1 expression by RNA interference promotes the aggressive properties of glioma cells via EGFR/Akt/c-Myc activation
- (2012) RUIFAN XIE et al. ONCOLOGY REPORTS
- Identifying common prognostic factors in genomic cancer studies: A novel index for censored outcomes
- (2010) Sigrid Rouam et al. BMC BIOINFORMATICS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started